[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
July 1999

The Role of Mycophenolate Mofetil in the Management of Pemphigus

Author Affiliations

Not Available

Arch Dermatol. 1999;135(7):853-854. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-7-dlt0799

We read with great interest the article by Enk and Knop1 and the accompanying editorial by Stanley.2 We were very impressed with the dramatic and rapid improvement obtained in 12 patients with pemphigus vulgaris with the use of mycophenolate mofetil, 2 g/d, as a steroid-sparing immunosuppressive agent. However, based on our own experience treating patients with autoimmune and inflammatory skin diseases, we feel that there are 3 aspects of this article that deserve further discussion and comment.

First Page Preview View Large
First page PDF preview
First page PDF preview